5 matches for your search in the start-up spotlight
rss
Startup will use funds to fine-tune their AI models for diagnostics and biomarker discovery
05-Sep-2024
The Berlin-based startup Lucid Genomics, a spin-off from the Max Planck Institute for Molecular Genetics and the Institute of Medical Genetics and Human Genetics at the Charité - Universitätsmedizin Berlin, has raised €1.3 million in pre-seed funding in a funding round led by Caesar Ventures, ...
AI from a Berlin start-up is used for this purpose
06-Mar-2024
Researchers at Charité's German Heart Center and the Mayo Clinic in the USA are conducting a new study to find out how patients with advanced heart failure can be monitored telemedically using the sound of their voice. Artificial intelligence from a Berlin start-up is being used for this. "Once ...
Berlin start-up could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process
01-Aug-2023
To help bring therapies for rare muscle diseases in children to market sooner, the Berlin-based start-up MyoPax, a spin-off from the Max Delbrück Center and Charité – Universitätsmedizin Berlin, has now received a boost from the U.S. Food and Drug Administration (FDA). The company has been ...
Spin-off company pinpoints the best time to exercise, sleep and take medicine
24-May-2023
An interdisciplinary team led by Prof. Angelo Relógio, a scientist at Charité’s Molecular Cancer Research Center (MKFZ) and Institute for Theoretical Biology and the MSH Medical School Hamburg, has developed a non-invasive method for profiling a person’s unique circadian rhythm. Starting with a ...
Drug targets were identified
23-Dec-2020
Like all viruses, the novel coronavirus is dependent on help from the human host cell. Proteins are the functional units of the cell and enable the virus to enter the host cell or help the virus to replicate. Scientists from the Berlin Institute of Health (BIH), Charité – Universitätsmedizin ...
